JAK2-IN-6
Product Specifications
UNSPSC Description
JAK2-IN-6, a multiple-substituted aminothiazole derivative, is a potent and selective JAK2 inhibitor with an IC50 of 22.86 μg/mL. JAK2-IN-6 shows no activity against JAK1 and JAK3. JAK2-IN-6 has anti-proliferative effect against cancer cells[1].
Target Antigen
JAK
Type
Reference compound
Related Pathways
Epigenetics;JAK/STAT Signaling;Protein Tyrosine Kinase/RTK;Stem Cell/Wnt
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/jak2-in-6.html
Smiles
O=C(C1=C(N)N=C(NC2=CC=CC=C2)S1)C3=CC=C(Cl)S3
Molecular Weight
335.841
References & Citations
[1]Ting-Ting Yao, et al. Integration of pharmacophore mapping and molecular docking in sequential virtual screening: towards the discovery of novel JAK2 inhibitors. RSC Adv., 2017, 7, 10353-10360.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-137756/JAK2-IN-6-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-137756/JAK2-IN-6-SDS-MedChemExpress.pdf
CAS Number
353512-04-6
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6494743-01 0.2 mL
Prostacyclin Synthase, NT (Prostaglandin I2 Synthase, CYP8A1, PTGIS, CYP8, CYP8A1) (AP)
Ask
View Details 
MBS6494743-02 5x 0.2 mL
Prostacyclin Synthase, NT (Prostaglandin I2 Synthase, CYP8A1, PTGIS, CYP8, CYP8A1) (AP)
Ask
View Details 